Reuters logo
BRIEF-Boston Scientific announces positive results from the Reprise III clinical trial
May 16, 2017 / 10:56 AM / 7 months ago

BRIEF-Boston Scientific announces positive results from the Reprise III clinical trial

May 16 (Reuters) - Boston Scientific Corp

* The Boston Scientific LOTUS™ valve system demonstrated superior efficacy to Corevalve® in global reprise III trial at one year

* Boston Scientific Corp says LOTUS valve system also demonstrated non-inferiority to corevalve platform for primary safety endpoint

* Boston Scientific - secondary endpoint demonstrated LOTUS valve system had lower rates of moderate to severe pvl occurrences compared to corevalve platform

* Boston Scientific Corp - LOTUS valve system showed superiority over corevalve tavi system platform for primary effectiveness endpoint Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below